Zeitoun, Khaled

Deficient 17β-Hydroxysteroid Dehydrogenase Type 2 Expression in Endometriosis: Failure to Metabolize 17β-Estradiol1

Zeitoun, K., Takayama, K., Sasano, H., Suzuki, T., Moghrabi, N., Andersson, S., Johns, A., Meng, L., Putman, M., Carr, B., et al. (1998) · The Journal of Clinical Endocrinology & Metabolism

Endometriosis Research and TreatmentEstrogen and related hormone effects

Cited by 308

Treatment of severe postmenopausal endometriosis with an aromatase inhibitor

Takayama, K., Zeitoun, K., Gunby, R. T., Sasano, H., Carr, B. R., & Bulun, S. E. (1998) · Fertility and Sterility

Endometriosis Research and TreatmentEndometrial and Cervical Cancer Treatments

Cited by 270

Aromatase: a key molecule in the pathophysiology of endometriosis and a therapeutic target

Zeitoun, K. M., & Bulun, S. E. (1999) · Fertility and Sterility

Endometriosis Research and TreatmentEstrogen and related hormone effects

Cited by 256

Stimulation of Aromatase P450 Promoter (II) Activity in Endometriosis and Its Inhibition in Endometrium Are Regulated by Competitive Binding of Steroidogenic Factor-1 and Chicken Ovalbumin Upstream Promoter Transcription Factor to the Same cis-Acting Element

Zeitoun, K., Takayama, K., Michael, M. D., & Bulun, S. E. (1999) · Molecular Endocrinology

Endometriosis Research and TreatmentEstrogen and related hormone effects

Cited by 216

Progesterone Receptor Isoform A But Not B Is Expressed in Endometriosis1

Attia, G. R., Zeitoun, K., Edwards, D., Johns, A., Carr, B. R., & Bulun, S. E. (2000) · The Journal of Clinical Endocrinology & Metabolism

Endometriosis Research and TreatmentEstrogen and related hormone effects

Cited by 193